Delivery Order SPE2DB22D2005-SPE2DB25FJTL3
- Not listed
- The Defense Logistics Agency awarded a $1,139.94 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL). This firm fixed-price contract, which is not set-aside designated, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) with a ceiling value of $1,148.28. This is a firm fixed-price, non-set-aside contract utilizing a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. This delivery order...
- The Defense Logistics Agency awarded a $10,788.64 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with completion scheduled for September 22, 2025. This contract utilized firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) with a firm fixed price ceiling value of $1,290.77. This delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The contract is...
- The Defense Logistics Agency awarded a delivery order valued at $1,666.01 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5mL units, with a ceiling value of $5,780.82. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $9,408.60 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) under a firm fixed price contract type. The award, made on September 9, 2025, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same city....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,378.90 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside provisions and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,986.76 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a pharmaceutical product used for treating ear infections. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order contract valued at $2,288.30 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and anti-inflammatory medication used for ear infections. This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, which serves...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJTL3Delivery Order
The Defense Logistics Agency awarded a $5,759.97 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of September 24, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive portfolio under its DLA Troop Support Medical prime vendor contract encompasses a wide range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, specialty drugs, and medical devices across multiple therapeutic domains. The current delivery order for this antibiotic-corticosteroid otic suspension supports the Defense Logistics Agency's medical supply chain operations serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 9/23/25 |